Catalyst Pharmaceuticals: Q2 Earnings Insights

Catalyst Pharmaceuticals CPRX reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Earnings

Catalyst Pharmaceuticals beat estimated earnings by 64.71%, reporting an EPS of $0.28 versus an estimate of $0.17.

Revenue was up $16.75 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.02 which was followed by a 6.06% drop in the share price the next day.

Here's a look at Catalyst Pharmaceuticals's past performance:

To track all earnings releases for Catalyst Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.